IMR Press / EJGO / Volume 37 / Issue 2 / DOI: 10.12892/ejgo2820.2016

European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Open Access Original Research
Expression of cancer stem markers could be influenced by silencing of p16 gene in HeLa cervical carcinoma cells
Show Less
1 Department of Gynaecology and Obstetrics, Henan Provincial People's Hospital, Zhengzhou
2 Department of Gynaecology and Obstetrics, the First Affiliated Hospital, Zhengzhou University, Zhengzhou, China
Eur. J. Gynaecol. Oncol. 2016, 37(2), 221–225; https://doi.org/10.12892/ejgo2820.2016
Published: 10 April 2016
Abstract

Effect of the tumor suppression gene p16 on the biological characteristics of HeLa cervical carcinoma cells was explored. The expression of p16 protein was increased in HeLa tumor sphere cells, and no significant difference in tumor spheres from the first to the fourth passages. Compared with those of parental HeLa cells, the proportion of CD44+/CD24- and ABCG2+ cells increased significantly in tumor spheres. However after the cells were silenced by the p16-sh289 vector, expression of P16 protein and the cell number of CD44+/CD24- and ABCG2+ decreased. Moreover, HeLa cells with p16 gene silencing showed decreased abilities of sphere formation and matrigel invasion. More HeLa cells with p16 gene silence were needed for tumor formation in nude mice. Tumor size and weight in mouse model established with p16 gene silenced HeLa cells were less than those with HeLa parental cell model. The present results indicate that silencing of the p16 gene inhibits expression of cancer stem cell markers and tumorigenic ability of HeLa cells.
Keywords
p16
Gene silencing
HeLa cell
Cancer stem cell
shRNA
CD44
CD24
ABCG2
Share
Back to top